Stephanie Pitts

Alterations in the Global Proteome and Phosphoproteome in Third Generation EGFR TKI Resistance Reveal Drug Targets to Circumvent Resistance

Xu Zhang, Tapan K. Maity, Karen Ross et al. · Cancer Research · 2021 · 65 citations · Full text

Medicine, Oncology, Pharmacology +17

Quantitative Tyrosine Phosphoproteomics of Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor-treated Lung Adenocarcinoma Cells Reveals Potential Novel Biomarkers of Therapeutic Response

Xu Zhang, Tapan K. Maity, Manoj Kumar Kashyap et al. · Molecular & Cellular Proteomics · 2017 · 55 citations · Full text

Medicine, Oncology, Pharmacology +17

Widespread genetic heterogeneity of human ribosomal RNA genes

Wenjun Fan, Eetu Eklund, Rachel M. Sherman et al. · RNA · 2022 · 40 citations · Full text

Life Sciences, Genetics, Molecular Genetics +17

Soluble immune checkpoints: implications for cancer prognosis and response to immune checkpoint therapy and conventional therapies

Stephanie Pitts, Jeffrey Schlom, Renee N. Donahue · Journal of Experimental & Clinical Cancer Research · 2024 · 27 citations · Full text

Life Sciences, Immunology, Oncology +17

Genomic profiling of multiple sequentially acquired tumor metastatic sites from an “exceptional responder” lung adenocarcinoma patient reveals extensive genomic heterogeneity and novel somatic variants driving treatment response

Romi Biswas, Shaojian Gao, Constance M. Cultraro et al. · Molecular Case Studies · 2016 · 24 citations · Full text

Medicine, Genetics, Oncology +17